Annual EBITDA
-$23.76 M
+$17.28 M+42.10%
December 31, 2024
Summary
- As of March 2, 2025, RXST annual EBITDA is -$23.76 million, with the most recent change of +$17.28 million (+42.10%) on December 31, 2024.
- During the last 3 years, RXST annual EBITDA has risen by +$17.25 million (+42.06%).
- RXST annual EBITDA is now -118.25% below its all-time high of $130.20 million, reached on December 31, 2019.
Performance
RXST EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.40 M
-$219.00 K-4.23%
December 31, 2024
Summary
- As of March 2, 2025, RXST quarterly EBITDA is -$5.40 million, with the most recent change of -$219.00 thousand (-4.23%) on December 31, 2024.
- Over the past year, RXST quarterly EBITDA has increased by +$2.71 million (+33.42%).
- RXST quarterly EBITDA is now -117.00% below its all-time high of $31.75 million, reached on September 30, 2020.
Performance
RXST Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$23.76 M
+$2.71 M+10.24%
December 31, 2024
Summary
- As of March 2, 2025, RXST TTM EBITDA is -$23.76 million, with the most recent change of +$2.71 million (+10.24%) on December 31, 2024.
- Over the past year, RXST TTM EBITDA has increased by +$17.28 million (+42.10%).
- RXST TTM EBITDA is now -155.57% below its all-time high of $42.76 million, reached on June 30, 2021.
Performance
RXST TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RXST EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.1% | +33.4% | +42.1% |
| 3 y3 years | +42.1% | +33.4% | +42.1% |
| 5 y5 years | -118.3% | +33.4% | +42.1% |
RXST EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.9% | -4.2% | +65.2% | at high | +59.2% |
| 5 y | 5-year | -118.3% | +58.9% | -117.0% | +65.3% | -155.6% | +59.2% |
| alltime | all time | -118.3% | +58.9% | -117.0% | +65.3% | -155.6% | +59.2% |
RxSight EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$23.76 M(-42.1%) | -$5.40 M(+4.2%) | -$23.76 M(-10.2%) |
| Sep 2024 | - | -$5.18 M(-1.1%) | -$26.47 M(-18.1%) |
| Jun 2024 | - | -$5.24 M(-34.1%) | -$32.33 M(-15.5%) |
| Mar 2024 | - | -$7.95 M(-2.0%) | -$38.27 M(-6.7%) |
| Dec 2023 | -$41.04 M(-29.0%) | -$8.11 M(-26.6%) | -$41.04 M(-11.0%) |
| Sep 2023 | - | -$11.04 M(-1.2%) | -$46.12 M(-7.0%) |
| Jun 2023 | - | -$11.18 M(+4.4%) | -$49.62 M(-6.4%) |
| Mar 2023 | - | -$10.71 M(-18.9%) | -$52.99 M(-8.3%) |
| Dec 2022 | -$57.78 M | -$13.19 M(-9.3%) | -$57.78 M(-0.8%) |
| Sep 2022 | - | -$14.54 M(-0.1%) | -$58.22 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$14.55 M(-6.1%) | -$54.27 M(+5.6%) |
| Mar 2022 | - | -$15.50 M(+13.7%) | -$51.37 M(+25.3%) |
| Dec 2021 | -$41.01 M(-227.5%) | -$13.63 M(+28.8%) | -$41.01 M(<-9900.0%) |
| Sep 2021 | - | -$10.59 M(-9.2%) | $415.00 K(-99.0%) |
| Jun 2021 | - | -$11.65 M(+127.0%) | $42.76 M(+0.5%) |
| Mar 2021 | - | -$5.13 M(-118.5%) | $42.56 M(+32.4%) |
| Dec 2020 | $32.15 M(-75.3%) | $27.79 M(-12.5%) | $32.15 M(+637.1%) |
| Sep 2020 | - | $31.75 M(-367.9%) | $4.36 M(-115.9%) |
| Jun 2020 | - | -$11.85 M(-23.7%) | -$27.39 M(+76.3%) |
| Mar 2020 | - | -$15.54 M | -$15.54 M |
| Dec 2019 | $130.20 M | - | - |
FAQ
- What is RxSight annual EBITDA?
- What is the all time high annual EBITDA for RxSight?
- What is RxSight annual EBITDA year-on-year change?
- What is RxSight quarterly EBITDA?
- What is the all time high quarterly EBITDA for RxSight?
- What is RxSight quarterly EBITDA year-on-year change?
- What is RxSight TTM EBITDA?
- What is the all time high TTM EBITDA for RxSight?
- What is RxSight TTM EBITDA year-on-year change?
What is RxSight annual EBITDA?
The current annual EBITDA of RXST is -$23.76 M
What is the all time high annual EBITDA for RxSight?
RxSight all-time high annual EBITDA is $130.20 M
What is RxSight annual EBITDA year-on-year change?
Over the past year, RXST annual EBITDA has changed by +$17.28 M (+42.10%)
What is RxSight quarterly EBITDA?
The current quarterly EBITDA of RXST is -$5.40 M
What is the all time high quarterly EBITDA for RxSight?
RxSight all-time high quarterly EBITDA is $31.75 M
What is RxSight quarterly EBITDA year-on-year change?
Over the past year, RXST quarterly EBITDA has changed by +$2.71 M (+33.42%)
What is RxSight TTM EBITDA?
The current TTM EBITDA of RXST is -$23.76 M
What is the all time high TTM EBITDA for RxSight?
RxSight all-time high TTM EBITDA is $42.76 M
What is RxSight TTM EBITDA year-on-year change?
Over the past year, RXST TTM EBITDA has changed by +$17.28 M (+42.10%)